Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Ambinder

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Current Topics in Microbiology and Immunology|October 3, 2015
The Biology and Clinical Utility of EBV Monitoring in BloodJennifer Kanakry, Richard Ambinder
Open Forum Infectious Diseases|April 8, 2020
Cytomegalovirus in Adult Allogeneic Blood and Marrow Transplant Patients Before or Around the Period of Neutrophil Recovery: A Single-Center, Retrospective, Descriptive StudyIsabella Martin, Alexandra Valsamakis, Douglas Gladstone, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 6, 2006
Interferon-alpha2b with protease inhibitor-based antiretroviral therapy in patients with AIDS-associated Kaposi sarcoma: an AIDS malignancy consortium phase I trialSusan E Krown, Jeannette Y Lee, Lan Lin, et al.
Journal of Translational Medicine|October 12, 2012
Epigenetic silencing of the 3p22 tumor suppressor DLEC1 by promoter CpG methylation in non-Hodgkin and Hodgkin lymphomasZhaohui Wang, Lili Li, Xianwei Su, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumorsJianming Ying, Gopesh Srivastava, Wen-Son Hsieh, et al.
Research Square|November 21, 2023
Nelfinavir Inhibition of Kaposi's sarcoma-associated herpesvirus protein expression and capsid assemblyMaggie Li, Barbara Smith, Lee Jaeyeun, et al.
Blood|May 10, 2015
AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphomaAriela Noy, Jeannette Y Lee, Ethel Cesarman, et al.
Plos One|February 11, 2009
Human T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphomaLee Ratner, William Harrington, Xuan Feng, et al.
Journal for Immunotherapy of Cancer|February 20, 2021
Use of pembrolizumab with or without pomalidomide in HIV-associated non-Hodgkin's lymphomaKathryn Lurain, Ramya Ramaswami, Ralph Mangusan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 13, 2013
Phase III randomized study of rituximab/carmustine, etoposide, cytarabine, and melphalan (BEAM) compared with iodine-131 tositumomab/BEAM with autologous hematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: results from the BMT CTN 0401 trialJulie M Vose, Shelly Carter, Linda J Burns, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Current Topics in Microbiology and Immunology|October 3, 2015
The Biology and Clinical Utility of EBV Monitoring in BloodJennifer Kanakry, Richard Ambinder
Open Forum Infectious Diseases|April 8, 2020
Cytomegalovirus in Adult Allogeneic Blood and Marrow Transplant Patients Before or Around the Period of Neutrophil Recovery: A Single-Center, Retrospective, Descriptive StudyIsabella Martin, Alexandra Valsamakis, Douglas Gladstone, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 6, 2006
Interferon-alpha2b with protease inhibitor-based antiretroviral therapy in patients with AIDS-associated Kaposi sarcoma: an AIDS malignancy consortium phase I trialSusan E Krown, Jeannette Y Lee, Lan Lin, et al.
Journal of Translational Medicine|October 12, 2012
Epigenetic silencing of the 3p22 tumor suppressor DLEC1 by promoter CpG methylation in non-Hodgkin and Hodgkin lymphomasZhaohui Wang, Lili Li, Xianwei Su, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumorsJianming Ying, Gopesh Srivastava, Wen-Son Hsieh, et al.
Research Square|November 21, 2023
Nelfinavir Inhibition of Kaposi's sarcoma-associated herpesvirus protein expression and capsid assemblyMaggie Li, Barbara Smith, Lee Jaeyeun, et al.
Blood|May 10, 2015
AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphomaAriela Noy, Jeannette Y Lee, Ethel Cesarman, et al.
Plos One|February 11, 2009
Human T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphomaLee Ratner, William Harrington, Xuan Feng, et al.
Journal for Immunotherapy of Cancer|February 20, 2021
Use of pembrolizumab with or without pomalidomide in HIV-associated non-Hodgkin's lymphomaKathryn Lurain, Ramya Ramaswami, Ralph Mangusan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 13, 2013
Phase III randomized study of rituximab/carmustine, etoposide, cytarabine, and melphalan (BEAM) compared with iodine-131 tositumomab/BEAM with autologous hematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: results from the BMT CTN 0401 trialJulie M Vose, Shelly Carter, Linda J Burns, et al.
Pageof 3